Quest Diagnostics (DGX) Tops Q4 EPS by 2c, Offers Guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $209.88 +1.76%
EPS Growth %: +7.6%
Financial Fact:
Operating income: 322M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +7.6%
Financial Fact:
Operating income: 322M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.40, $0.02 better than the analyst estimate of $1.38. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.94 billion.
GUIDANCE:
Quest Diagnostics sees FY2018 EPS of $6.50-$6.70, versus the consensus of $6.61.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
- Quest Diagnostics wins New York approval for cancer MRD test
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
